Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

March 3, 2010

Primary Completion Date

March 10, 2016

Study Completion Date

July 11, 2016

Conditions
Fallopian Tube CancerMetastatic CancerOvarian CancerPeritoneal Cavity Cancer
Interventions
DRUG

carboplatin

Carboplatin AUC 5 if measured GFR or AUC6 if calculated GFR intravenous or intraperitoneal.

DRUG

cisplatin

Cisplatin 75 mg/m2 intraperitoneal day 1

DRUG

paclitaxel

Paclitaxel 135 mg/m2 intravenous day 1 plus Paclitaxel 60 mg/m2 intraperitoneal or intravenously day 8. Cycles given Q 21 days x 3 cycles

Trial Locations (50)

28009

Hospital Gregorio Maranon, Madrid

28033

Centro Oncologico MD Anderson - Madrid, Madrid

28040

Hospital Clinico San Carlos, Madrid

28922

Hospital Fundacion Alcorcon, Alcorcón

46009

Fundacion Instituto Valenciano de Oncologia, Valencia

46010

Hospital Clinico Universitario de Valencia, Valencia

65804

Mercy-Springfield, Springfield

65807

CoxHealth, Springfield

84132

Univ of Utah (Huntsman Cancer Institute), Salt Lake City

98415

Northwest CCOP - Multicare Health System, Tacoma

73190-0001

University of Oklahoma Health Sciences Center, Oklahoma City

02905

Women and Infants Hospital of Rhode Island, Providence

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V1Y 5L3

BCCA - Cancer Centre for the Southern Interior, Kelowna

V3V 1Z2

BCCA - Fraser Valley Cancer Centre, Surrey

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

R3E 0V9

CancerCare Manitoba, Winnipeg

E2L 4L2

Regional Health Authority B, Zone 2, Saint John

A1B 3V6

Dr. H. Bliss Murphy Cancer Centre, St. John's

B3H 1V7

QEII Health Sciences Centre, Halifax

K7L 5P9

Cancer Centre of Southeastern Ontario at Kingston, Kingston

N6A 4L6

London Regional Cancer Program, London

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

P7B 6V4

Thunder Bay Regional Health Science Centre, Thunder Bay

M5G 2M9

Univ. Health Network-Princess Margaret Hospital, Toronto

H1T 2M4

Hopital Maisonneuve-Rosemont, Montreal

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

H2W 1S6

McGill University - Dept. Oncology, Montreal

G1R 2J6

CHUQ-Pavillon Hotel-Dieu de Quebec, Québec

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

08908

Instituto Catalan de Oncologia - L'Hospitalet, L'Hospitalet de Llobregat

08035

Hospital Vall d'Hebron, Barcelona

08036

Corporacio Sanitaria Clinic, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

CH63 4JY

The Clatterbridge Center for Oncology - Liverpool, Metropolitan Borough of Wirral

HA6 2RN

Mount Vernon Hospital - Middlesex, Middlesex

SW17 0QT

St. George's Hospital - London, London

SL2 4HL

Wexham Park Hospital, Slough

M20 4BX

The Christie Hospital - Manchester, Manchester

EH4 2XU

The Western General Hospital - Edinburgh, Edinburgh

LS9 7TF

St. James University Hospital - Leeds, Leeds

L8 755

Liverpool Women's Hospital - Liverpool, Liverpool

EC1M 6BQ

St. Bartholomew's Hospital - London, London

SW3 6JJ

The Royal Marsden Hospital - London, London

W12 0HS

The Hammersmith Hospital - London, London

W1T 4TJ

University College London Hospital - London, London

M13 0JH

St Marys Hospital - Manchester, Manchester

OX3 7LJ

The Churchill Hospital - Oxford, Oxford

PL6 8DH

The Derriford Hospital - Plymouth, Plymouth

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Grupo Español de Investigación en Cáncer de Ovario

OTHER

collaborator

Cancer Research UK

OTHER

collaborator

SWOG Cancer Research Network

NETWORK

lead

Canadian Cancer Trials Group

NETWORK